HANNARİCİ, Z. Et Al. 2023. The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer. FUTURE ONCOLOGY , vol.19, no.4 , 315-325.

HANNARİCİ, Z., Yilmaz, A., Buyukbayram, M. E., TURHAN, A., ÇAĞLAR, A. A., BİLİCİ, M., ... TEKİN, S. B.(2023). The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer. FUTURE ONCOLOGY , vol.19, no.4, 315-325.

HANNARİCİ, Zekeriya Et Al. "The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer," FUTURE ONCOLOGY , vol.19, no.4, 315-325, 2023

HANNARİCİ, Zekeriya Et Al. "The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer." FUTURE ONCOLOGY , vol.19, no.4, pp.315-325, 2023

HANNARİCİ, Z. Et Al. (2023) . "The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer." FUTURE ONCOLOGY , vol.19, no.4, pp.315-325.

@article{article, author={Zekeriya HANNARİCİ Et Al. }, title={The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer}, journal={FUTURE ONCOLOGY}, year=2023, pages={315-325} }